For John Lumley, who is in his 11th year as a sales rep in Johnstown, PA, for Janssen Pharmaceutica, working in a small town is challenging, but lends a valuable perspective on the personal aspects of selling. Without access to the events and programs available in metropolitan areas, he has learned to watch for unique opportunities to make contact with his physicians and take the time to get to know them as individuals.
For John Lumley, who is in his 11th year as a sales rep in Johnstown, PA, for Janssen Pharmaceutica, working in a small town is challenging, but lends a valuable perspective on the personal aspects of selling. Without access to the events and programs available in metropolitan areas, he has learned to watch for unique opportunities to make contact with his physicians and take the time to get to know them as individuals.
As Lumley pointed out, "access is tough wherever you go, whether it's a big town or a small town." So he goes beyond the typical tactics for gaining no-see doctors' attention and makes special efforts to interact with them in places outside the waiting room, like local hospitals' picnics. He even helped one physician's staff paint their office, and another's move to a new location, with laudable results. He now enjoys "incredible access" at those offices.
Once a social worker, Lumley has experience catering to a variety of people, and molds his selling techniques to doctors' personalities and moods. Sometimes that means stepping back in the short term if a physician isn't receptive. "You should be able to read them and say, this is not a day that I pull out the brochure, give a whole presentation and close them. I'll show up tomorrow." Over time, this approach has allowed him to build a rapport with his physicians. One doctor recently took him out for nine holes of golf, a beer and a sandwich, which Lumley takes as a sign of long-term success. "I look at it as a marathon, not a sprint."
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.